JP2023550381A5 - - Google Patents

Info

Publication number
JP2023550381A5
JP2023550381A5 JP2023529965A JP2023529965A JP2023550381A5 JP 2023550381 A5 JP2023550381 A5 JP 2023550381A5 JP 2023529965 A JP2023529965 A JP 2023529965A JP 2023529965 A JP2023529965 A JP 2023529965A JP 2023550381 A5 JP2023550381 A5 JP 2023550381A5
Authority
JP
Japan
Prior art keywords
protein
cells
sequence
coding sequence
lentivirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023529965A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550381A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/060099 external-priority patent/WO2022109275A2/en
Publication of JP2023550381A publication Critical patent/JP2023550381A/ja
Publication of JP2023550381A5 publication Critical patent/JP2023550381A5/ja
Pending legal-status Critical Current

Links

JP2023529965A 2020-11-19 2021-11-19 真核生物遺伝子編集のためのベクター、システムおよび方法 Pending JP2023550381A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063115932P 2020-11-19 2020-11-19
US63/115,932 2020-11-19
PCT/US2021/060099 WO2022109275A2 (en) 2020-11-19 2021-11-19 Vectors, systems and methods for eukaryotic gene editing

Publications (2)

Publication Number Publication Date
JP2023550381A JP2023550381A (ja) 2023-12-01
JP2023550381A5 true JP2023550381A5 (cg-RX-API-DMAC7.html) 2024-11-20

Family

ID=79927283

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023529965A Pending JP2023550381A (ja) 2020-11-19 2021-11-19 真核生物遺伝子編集のためのベクター、システムおよび方法

Country Status (6)

Country Link
US (1) US20230405116A1 (cg-RX-API-DMAC7.html)
EP (1) EP4247951A2 (cg-RX-API-DMAC7.html)
JP (1) JP2023550381A (cg-RX-API-DMAC7.html)
AU (1) AU2021381397A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196996A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022109275A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220259617A1 (en) 2019-06-13 2022-08-18 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
BR112023001272A2 (pt) 2020-07-24 2023-04-04 Massachusetts Gen Hospital Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3957731A1 (en) * 2015-07-15 2022-02-23 Rutgers, The State University of New Jersey Nuclease-independent targeted gene editing platform and uses thereof
AU2017263137B2 (en) * 2016-05-13 2021-05-27 Flash Therapeutics Particle for the encapsidation of a genome engineering system
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
KR102678809B1 (ko) * 2017-05-18 2024-06-26 더 브로드 인스티튜트, 인코퍼레이티드 표적화된 핵산 편집을 위한 시스템, 방법 및 조성물
CN111328290A (zh) * 2017-06-26 2020-06-23 博德研究所 用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法
WO2019213257A1 (en) * 2018-05-01 2019-11-07 Wake Forest University Health Sciences Lentiviral-based vectors and related systems and methods for eukaryotic gene editing
US20210261957A1 (en) * 2018-07-10 2021-08-26 Alia Therapeutics S.R.L. Vesicles for traceless delivery of guide rna molecules and/or guide rna molecule/rna-guided nuclease complex(es) and a production method thereof
AU2020466994B2 (en) * 2019-09-17 2026-05-28 Rutgers, The State University Of New Jersey Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof

Similar Documents

Publication Publication Date Title
JP2021522783A5 (cg-RX-API-DMAC7.html)
KR102455623B1 (ko) CRISPR/Cas12f1 시스템 효율화를 위한 엔지니어링 된 가이드 RNA 및 그 용도
CA3149897A1 (en) Methods and compositions for genomic integration
CN109415415B (zh) 用于衣壳化基因组工程系统的颗粒
JP2024520528A (ja) Crisprヌクレアーゼを含む遺伝子編集システム及びそれらの使用
CA3120282A1 (en) Fusosome compositions for hematopoietic stem cell delivery
KR102690083B1 (ko) CRISPR/Cas12f1 시스템 효율화를 위한 U-rich tail을 포함하는 엔지니어링 된 가이드 RNA 및 그 용도
KR20200083550A (ko) ACE-tRNA에 의한 유전자 재지정을 통해 정지 코돈을 구조하는 방법
US20190374567A1 (en) Reverse Transcriptase Dependent Conversion of RNA Templates Into DNA
KR20050084302A (ko) 자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터
WO1994003622A1 (en) D-type retroviral vectors, based on mpmv
JP2024506910A5 (cg-RX-API-DMAC7.html)
EP4448549A2 (en) Modified paramyxoviridae fusion glycoproteins
WO2023115041A1 (en) Modified paramyxoviridae attachment glycoproteins
KR20200135225A (ko) 단일염기 치환 단백질 및 이를 포함하는 조성물
KR20230007218A (ko) 초소형 염기교정 시스템 및 이의 용도
JP2025524620A (ja) 暗号化rna及びその使用方法
JP2025510574A5 (cg-RX-API-DMAC7.html)
US20230405116A1 (en) Vectors, systems and methods for eukaryotic gene editing
KR20250012711A (ko) CRISPR/Cas12f1 시스템 효율화를 위한 엔지니어링 된 가이드 RNA 및 그 용도
JP5246904B2 (ja) 外来遺伝子導入用ベクター及び外来遺伝子が導入されたベクターの製造方法
JP2025516484A5 (cg-RX-API-DMAC7.html)
CN116355100A (zh) 一种碱基编辑器及其构建方法与应用
CN121342932B (zh) 许氏平鲉内源性逆转录病毒包膜蛋白P_env、慢病毒载体及其应用
WO2026067648A1 (en) Type ii cas protein and uses thereof